BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,799,317 | -20.7% | 155,303 | -0.2% | 0.01% | -16.7% |
| Q2 2023 | $9,835,879 | +103.5% | 155,631 | +44.8% | 0.01% | +100.0% |
| Q1 2023 | $4,834,265 | +2.6% | 107,452 | -0.1% | 0.01% | -14.3% |
| Q4 2022 | $4,713,386 | -33.8% | 107,587 | -0.4% | 0.01% | -30.0% |
| Q3 2022 | $7,115,658 | +73.6% | 107,993 | +33.1% | 0.01% | 0.0% |
| Q2 2022 | $4,099,000 | -44.9% | 81,155 | -30.3% | 0.01% | -33.3% |
| Q1 2022 | $7,438,000 | -3.6% | 116,444 | +61.6% | 0.02% | 0.0% |
| Q4 2021 | $7,719,000 | -51.5% | 72,062 | -53.4% | 0.02% | -53.1% |
| Q3 2021 | $15,910,000 | +47.2% | 154,749 | +26.0% | 0.03% | +52.4% |
| Q2 2021 | $10,805,000 | -24.8% | 122,838 | -16.9% | 0.02% | -27.6% |
| Q1 2021 | $14,377,000 | -24.2% | 147,860 | -12.6% | 0.03% | -23.7% |
| Q4 2020 | $18,967,000 | -6.8% | 169,117 | -23.0% | 0.04% | -15.6% |
| Q3 2020 | $20,354,000 | +32.2% | 219,573 | +11.3% | 0.04% | +25.0% |
| Q2 2020 | $15,394,000 | +8.8% | 197,350 | -18.4% | 0.04% | -5.3% |
| Q1 2020 | $14,145,000 | -29.9% | 241,855 | -3.9% | 0.04% | -9.5% |
| Q4 2019 | $20,165,000 | -21.0% | 251,706 | -27.6% | 0.04% | -25.0% |
| Q3 2019 | $25,532,000 | +8.9% | 347,500 | +39.7% | 0.06% | +12.0% |
| Q2 2019 | $23,456,000 | -11.2% | 248,664 | -24.6% | 0.05% | -15.3% |
| Q1 2019 | $26,415,000 | +28.6% | 329,985 | -13.4% | 0.06% | +15.7% |
| Q4 2018 | $20,542,000 | -43.4% | 381,032 | -18.0% | 0.05% | -32.0% |
| Q3 2018 | $36,292,000 | +30.9% | 464,928 | +6.4% | 0.08% | +27.1% |
| Q2 2018 | $27,734,000 | -4.7% | 436,894 | +37.6% | 0.06% | -4.8% |
| Q1 2018 | $29,114,000 | +1943.1% | 317,488 | +1580.4% | 0.06% | +1966.7% |
| Q4 2017 | $1,425,000 | +12.4% | 18,894 | +3.8% | 0.00% | 0.0% |
| Q3 2017 | $1,268,000 | +37.5% | 18,194 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $922,000 | +143.9% | 18,194 | +92.3% | 0.00% | +100.0% |
| Q1 2017 | $378,000 | +42.6% | 9,460 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $265,000 | -5.7% | 9,460 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $281,000 | – | 9,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |